VA
STIM icon

VestGen Advisors’s Neuronetics STIM Stock Holding History

VestGen Advisors’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65.4K Sell
50,279
-50,134
-50% -$72.9K ﹤0.01% 1076
2026
Q1 		$128K Buy
+100,413
New +$159K ﹤0.01% 1024

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VestGen Advisors's STIM Position: Q2 2026 in Review

VestGen Advisors reduced its Neuronetics (STIM) stake by 50% in Q2 2026, selling an estimated $72.9K and leaving 50,279 shares worth $65.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1076.

VestGen Advisors first reported a position in STIM in Q1 2026 and has held it in 2 quarters since. The position peaked at $128K in Q1 2026. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • VestGen Advisors held 50,279 shares of Neuronetics worth $65.4K as of Q2 2026.
  • VestGen Advisors sold 50,134 Neuronetics shares in Q2 2026, an estimated $72.9K.
  • Neuronetics made up ﹤0.01% of VestGen Advisors's portfolio in Q2 2026, its #1076 holding.
  • VestGen Advisors first reported a position in Neuronetics in Q1 2026 and has held it in 2 quarters since.
  • VestGen Advisors's Neuronetics position peaked at $128K in Q1 2026.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on VestGen Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.